Take-Two Interactive Softwar (TTWO) Misses Q4 EPS by 5c; Guides to Q2 Loss
Get Alerts TTWO Hot Sheet
Price: $241.91 -0.45%
Financial Fact:
Basic earnings (loss) per share (in dollars per share): 0.42
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Basic earnings (loss) per share (in dollars per share): 0.42
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Take-Two Interactive Softwar (Nasdaq: TTWO) reported Q4 EPS of ($0.60), $0.05 worse than the analyst estimate of ($0.55). Revenue for the quarter came in at $148.1 million versus the consensus estimate of $139.86 million.
Take-Two Interactive Softwar sees FY2013 EPS of $2.00-$2.25, versus the consensus of $2.77. Take-Two Interactive Softwar sees FY2013 revenue of $1.75-$1.85 billion, versus the consensus of $1.80 billion.
Take-Two Interactive Softwar sees Q1 2013 EPS of $-0.75-$-0.60, versus the consensus of $0.14. Take-Two Interactive Softwar sees Q1 2013 revenue of $225-$275 million, versus the consensus of $302.08 million.
For earnings history and earnings-related data on Take-Two Interactive Softwar (TTWO) click here.
Take-Two Interactive Softwar sees FY2013 EPS of $2.00-$2.25, versus the consensus of $2.77. Take-Two Interactive Softwar sees FY2013 revenue of $1.75-$1.85 billion, versus the consensus of $1.80 billion.
Take-Two Interactive Softwar sees Q1 2013 EPS of $-0.75-$-0.60, versus the consensus of $0.14. Take-Two Interactive Softwar sees Q1 2013 revenue of $225-$275 million, versus the consensus of $302.08 million.
For earnings history and earnings-related data on Take-Two Interactive Softwar (TTWO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- 4D Molecular Therapeutics, Inc. (FDMT) Misses Q2 EPS by 3c
- MapLight Therapeutics, Inc. (MPLT) Misses Q2 EPS by 33c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share